149 related articles for article (PubMed ID: 34944522)
1. Characterization of
Vlasenkova R; Nurgalieva A; Akberova N; Bogdanov M; Kiyamova R
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944522
[TBL] [Abstract][Full Text] [Related]
2. High expression of SLC34A2 is a favorable prognostic marker in lung adenocarcinoma patients.
Zhang Z; Ye S; Zhang M; Wu J; Yan H; Li X; He J
Tumour Biol; 2017 Jul; 39(7):1010428317720212. PubMed ID: 28720066
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of SLC34A2 expression in different types of ovarian tumors.
Shyian M; Gryshkova V; Kostianets O; Gorshkov V; Gogolev Y; Goncharuk I; Nespryadko S; Vorobjova L; Filonenko V; Kiyamova R
Exp Oncol; 2011 Jun; 33(2):94-8. PubMed ID: 21716206
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity.
Ye W; Chen C; Gao Y; Zheng ZS; Xu Y; Yun M; Weng HW; Xie D; Ye S; Zhang JX
Cell Death Dis; 2017 Feb; 8(2):e2581. PubMed ID: 28151475
[TBL] [Abstract][Full Text] [Related]
5. SLC34A2 as a novel marker for diagnosis and targeted therapy of breast cancer.
Chen DR; Chien SY; Kuo SJ; Teng YH; Tsai HT; Kuo JH; Chung JG
Anticancer Res; 2010 Oct; 30(10):4135-40. PubMed ID: 21036732
[TBL] [Abstract][Full Text] [Related]
6. Novel deletion of
Dandan S; Yuqin C; Wei L; Ziheng P; Dapeng Z; Jianzhu Y; Xin X; Yonghong L; Fengjun T
J Genet; 2018 Sep; 97(4):939-944. PubMed ID: 30262706
[TBL] [Abstract][Full Text] [Related]
7. Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer.
Liu L; Yang Y; Zhou X; Yan X; Wu Z
Biomed Pharmacother; 2018 Mar; 99():645-654. PubMed ID: 29653487
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells.
Yang W; Wang Y; Pu Q; Ye S; Ma Q; Ren J; Zhong G; Liu L; Zhu W
Mol Med Rep; 2014 Sep; 10(3):1205-14. PubMed ID: 25017204
[TBL] [Abstract][Full Text] [Related]
9. TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database.
Li VD; Li KH; Li JT
J Cancer Res Clin Oncol; 2019 Mar; 145(3):625-636. PubMed ID: 30542790
[TBL] [Abstract][Full Text] [Related]
10. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
Bao Z; Chen L; Guo S
J Cell Biochem; 2019 Jun; 120(6):10205-10214. PubMed ID: 30592329
[TBL] [Abstract][Full Text] [Related]
12. SLC34A2 Gene mutation of pulmonary alveolar microlithiasis: report of four cases and review of literatures.
Yin X; Wang H; Wu D; Zhao G; Shao J; Dai Y
Respir Med; 2013 Feb; 107(2):217-22. PubMed ID: 23164546
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer.
Wu K; Liao X; Gong Y; He J; Zhou JK; Tan S; Pu W; Huang C; Wei YQ; Peng Y
Mol Cancer; 2019 May; 18(1):98. PubMed ID: 31118036
[TBL] [Abstract][Full Text] [Related]
14. SLC34A2 regulates miR-25-Gsk3β signaling pathway to affect tumor progression in gastric cancer stem cell-like cells.
Zhang L; Guo X; Zhang L; Yang F; Qin L; Zhang D; Qin Y
Mol Carcinog; 2018 Mar; 57(3):440-450. PubMed ID: 29178392
[TBL] [Abstract][Full Text] [Related]
15. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
[TBL] [Abstract][Full Text] [Related]
16. The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer.
Li X; Xing J; Wang H; Yu E
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30038060
[TBL] [Abstract][Full Text] [Related]
17. [Detection of SLC34A2 in patients with pulmonary alveolar microlithiasis and the effect of SLC34A2 on transportation of calcium and phosphate in human alveolar epithelial cells].
Yang Y; Qiao JH; An JH; Zhang Y; Yu T; Jia B; Ma ZS
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):908-11. PubMed ID: 19134407
[TBL] [Abstract][Full Text] [Related]
18. Characterizing and evaluating the expression of the type IIb sodium-dependent phosphate cotransporter (slc34a2) gene and its potential influence on phosphorus utilization efficiency in yellow catfish (Pelteobagrus fulvidraco).
Chen P; Tang Q; Wang C
Fish Physiol Biochem; 2016 Feb; 42(1):51-64. PubMed ID: 26298316
[TBL] [Abstract][Full Text] [Related]
19. [Expression of selected genes involved in transport of ions in papillary thyroid carcinoma].
Gałeza-Kulik M; Zebracka J; Szpak-Ulczok S; Czarniecka AK; Kukulska A; Gubała E; Stojcev Z; Wiench M
Endokrynol Pol; 2006; 57 Suppl A():26-31. PubMed ID: 17091453
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate.
Wu D; Hu S; Hou Y; He Y; Liu S
BMC Cancer; 2020 Mar; 20(1):199. PubMed ID: 32164602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]